$930,000
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Mulay JamesJan 9, 2026Sell654$44.16$29,000
Mulay JamesJan 9, 2026Sell10,491$52.99$560,000
POST LEONARD ENov 17, 2025Sell1,000$41.43$41,000
POST LEONARD EOct 13, 2025Sell1,000$43.25$43,000
Mulay JamesOct 9, 2025Sell5,903$43.99$260,000
POST LEONARD ESep 30, 2025Sell5,000$40.09$200,000
Mulay JamesSep 29, 2025Sell12,755$39.19$500,000
Mulay JamesSep 19, 2025Sell3,574$38.99$140,000
Mulay JamesSep 18, 2025Sell19,112$39.01$750,000
POST LEONARD ESep 15, 2025Sell1,000$35.1$35,000
Liu Brian Guan-ChyunSep 11, 2025Buy1,515,151$33$50M
Mulay JamesSep 5, 2025Sell12,342$30.47$380,000
Mulay JamesSep 5, 2025Sell3,113$33.22$100,000
Mulay JamesSep 5, 2025Sell4,095$31.42$130,000
Mulay JamesSep 5, 2025Sell7,465$32.64$240,000
POST LEONARD ESep 3, 2025Sell1,000$28$28,000
Song Hong FangSep 3, 2025Sell100$28.99$2,900
Song Hong FangSep 3, 2025Sell30,105$28.24$850,000
Song Hong FangSep 3, 2025Sell69,695$27.6$1.9M
POST LEONARD EJul 17, 2025Sell2,000$28$56,000
POST LEONARD EMay 21, 2025Sell1,000$28$28,000
POST LEONARD EApr 28, 2025Sell1,000$30.76$31,000
POST LEONARD EMar 17, 2025Sell1,000$28$28,000
POST LEONARD EFeb 18, 2025Sell1,000$28.61$29,000
POST LEONARD EJan 13, 2025Sell1,000$29.66$30,000
Song Hong FangDec 16, 2024Sell700,000$28$20M
POST LEONARD EDec 16, 2024Sell1,000$28.84$29,000
POST LEONARD EDec 6, 2024Sell750$34.3973$26,000
POST LEONARD EDec 6, 2024Sell250$34.976$8,700
Song Hong FangAug 29, 2024Sell226,245$35.36$8M
Song Hong FangAug 29, 2024Sell424,210$35.36$15M

FAQ - Insider Transactions

The most recent insider transaction for CG Oncology was conducted by Mulay James, who sold 654 shares on January 9, 2026 at a price of $44.16 per share.

Liu Brian Guan-Chyun has bought the most CGON stock in the last 2 years, with a total value of $50M.

Song Hong Fang has sold the most CGON stock in the last 2 years, with a total value of $45M.

According to our estimates, the total value of insider transactions for CG Oncology in the last 2 years is positive, amounting to $930,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.

Over the last 2 years, insider transactions for CG Oncology have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.